Subtopic Deep Dive

14-3-3 Proteins in Apoptosis Regulation
Research Guide

What is 14-3-3 Proteins in Apoptosis Regulation?

14-3-3 proteins regulate apoptosis by binding phosphorylated pro-apoptotic proteins like BAD and Bax, sequestering them to prevent mitochondrial translocation and cell death.

14-3-3 proteins interact with BAD via BH3 domain phosphorylation to inactivate it (Datta et al., 2000, 643 citations). JNK phosphorylates 14-3-3 to release Bax for mitochondrial translocation (Tsuruta et al., 2004, 556 citations). 14-3-3 directly binds Bax to inhibit its pro-apoptotic activity (Nomura et al., 2003, 340 citations). Over 10 key papers detail these mechanisms.

Curated Papers

Key Challenges

Why It Matters

In cancer cells, 14-3-3 sequestration of BAD promotes survival in PTEN-deficient tumors (She et al., 2005, 415 citations), making it a target for therapies restoring apoptosis. Modulating 14-3-3 interactions with Bax could sensitize tumors to chemotherapy (Nomura et al., 2003). Protein-protein interaction modulators targeting 14-3-3 are in clinical trials for oncology (Lu et al., 2020, 840 citations). Dysregulation links to neurodegeneration via α-synuclein homology (Ostrerova et al., 1999, 555 citations).

Key Research Challenges

Isoform-specific binding selectivity

14-3-3 has seven isoforms with overlapping yet distinct apoptosis roles, complicating targeted inhibition. Pennington et al. (2018, 376 citations) highlight context-dependent interactions. Dissecting isoform contributions requires proteomics in knockout models.

Dynamic phosphorylation regulation

Kinases like JNK and Akt reversibly phosphorylate 14-3-3 and partners like BAD/Bax, creating feedback loops. Tsuruta et al. (2004, 556 citations) show JNK phosphorylation releases Bax. Modeling these dynamics demands time-resolved studies.

Translating PPI modulation to clinic

Small molecules disrupting 14-3-3 interfaces face selectivity and toxicity issues. Lu et al. (2020, 840 citations) review clinical trials of PPI modulators. Validating efficacy in apoptosis-defective cancers needs patient-derived models.

Essential Papers

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Haiying Lu, Qiaodan Zhou, Jun He et al. · 2020 · Signal Transduction and Targeted Therapy · 840 citations

14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation

Sandeep Robert Datta, Alex Katsov, Linda Hu et al. · 2000 · Molecular Cell · 643 citations

Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway

Shigetoshi Yano, Hiroshi Tokumitsu, Thomas R. Soderling · 1998 · Nature · 616 citations

JNK promotes Bax translocation to mitochondria through phosphorylation of 14‐3‐3 proteins

Fuminori Tsuruta, Jun Sunayama, Yasunori Mori et al. · 2004 · The EMBO Journal · 556 citations

α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

Natalie Ostrerova, Leonard Petrucelli, Matthew J. Farrer et al. · 1999 · Journal of Neuroscience · 555 citations

α-Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease. Mutations in α-synuclein cause some cases of f...

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

Qing‐Bai She, David B. Solit, Qing Ye et al. · 2005 · Cancer Cell · 415 citations

The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions

Katie L. Pennington, Chan Ty, Matthew P. Torres et al. · 2018 · Oncogene · 376 citations

Reading Guide

Foundational Papers

Start with Datta et al. (2000, 643 citations) for BAD phosphorylation mechanism, then Tsuruta et al. (2004, 556 citations) for JNK-Bax pathway, and Nomura et al. (2003, 340 citations) for direct Bax interaction—these establish core anti-apoptotic sequestration.

Recent Advances

Study Pennington et al. (2018, 376 citations) for dynamic 14-3-3 hubs and Lu et al. (2020, 840 citations) for PPI modulators in clinical trials.

Core Methods

Phosphorylation consensus motifs (Petosa et al., 1998); co-IP and mitochondrial fractionation (Nomura et al., 2003); kinase inhibitors and knockout models (Tsuruta et al., 2004); PPI modulator screens (Lu et al., 2020).

How PapersFlow Helps You Research 14-3-3 Proteins in Apoptosis Regulation

Discover & Search

Research Agent uses searchPapers('14-3-3 BAD apoptosis') to find Datta et al. (2000, 643 citations), then citationGraph reveals downstream works like Tsuruta et al. (2004), and findSimilarPapers expands to 50+ related studies on Bax regulation.

Analyze & Verify

Analysis Agent applies readPaperContent on Nomura et al. (2003) to extract Bax binding motifs, verifyResponse with CoVe checks claims against abstracts from 10 papers, and runPythonAnalysis performs GRADE grading on kinase phosphorylation frequencies plus statistical verification of survival kinase cooperation from Datta et al. (2000).

Synthesize & Write

Synthesis Agent detects gaps in isoform-specific apoptosis data via contradiction flagging across Pennington et al. (2018) and Lu et al. (2020), while Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 643-citation Datta paper, and latexCompile for publication-ready reviews; exportMermaid generates BH3-binding interaction flowcharts.

Use Cases

"Extract apoptosis kinase data from 14-3-3 papers and plot phosphorylation rates"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on kinase frequencies from Datta 2000 and Tsuruta 2004) → researcher gets CSV plot of JNK vs Akt effects on BAD/Bax.

"Draft LaTeX review of 14-3-3 in cancer apoptosis with citations"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (She 2005, Lu 2020) + latexCompile → researcher gets compiled PDF with 14-3-3 PPI diagrams.

"Find GitHub code for 14-3-3 docking simulations"

Research Agent → paperExtractUrls (Petosa 1998) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets validated docking scripts for 14-3-3 amphipathic groove analysis.

Automated Workflows

Deep Research workflow scans 50+ papers on 14-3-3 apoptosis (e.g., Datta 2000 to Lu 2020) for structured report with citation networks and gap summaries. DeepScan's 7-step chain verifies BAD sequestration claims via CoVe checkpoints across Tsuruta (2004) and Nomura (2003). Theorizer generates hypotheses on isoform modulators from Pennington (2018) interaction data.

Try Doxa for 14-3-3 Proteins in Apoptosis Regulation Research

Frequently Asked Questions

What is the core mechanism of 14-3-3 in apoptosis?

14-3-3 binds phosphorylated BAD at BH3 domain to sequester it from mitochondria (Datta et al., 2000, 643 citations) and directly inhibits Bax (Nomura et al., 2003, 340 citations).

What methods study 14-3-3 apoptosis interactions?

Studies use phosphorylation site mutants, co-IP for binding, JNK knockout models for Bax release (Tsuruta et al., 2004, 556 citations), and PPI modulators (Lu et al., 2020).

What are key papers on 14-3-3 apoptosis regulation?

Datta et al. (2000, 643 citations) on BAD inactivation; Tsuruta et al. (2004, 556 citations) on JNK-Bax; Nomura et al. (2003, 340 citations) on direct Bax binding.

What open problems exist in 14-3-3 apoptosis research?

Isoform-specific roles in tumors (Pennington et al., 2018), clinical translation of PPI inhibitors (Lu et al., 2020), and dynamic kinase feedback modeling remain unresolved.